Matthew J Sorrentino MD

PubMed

• Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo.
  Bader Ali, Robert Shenkar, Justine Lee, Roberto J Alcazar-Felix, Richard E Thompson
  Journal of the American Heart Association. 2026-02-03
• 5 citations
  Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.
  Issam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, Serena Kinkade, Aditya Jhaveri
  The Lancet. Neurology. 2025-04-01
• The Bucksbaum Institute for Clinical Excellence and the Doctor-Patient Relationship: Origins, Programs, and Future Directions.
  Matthew Sorrentino, Joni Krapec, Adam S Cifu, Angela Pace-Moody, Mark Siegler
  Academic Medicine. 2023-06-01

Journal Articles

• Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial  
  Amy L Akers, Kevin J Whitehead, Gregory A Christoforidis, Daniel F Hanley, Kelly D Flemming, Sean P Polster, James K Liao, Matthew Sorrentino, Cornelia Lee, Issam A Aw..., Neurosurgery
• Short vs long-term DAPT after stent implantation Commentary on: Gargiulo G et al Short term versus long term dual antiplatelet therapy after implantation of drug eluti...  
  Sorrentino M, BMJ November, 1/1/2016
• Patient perceptions of care as influenced by a large institutional pharmacogenomic implementation program  
  McKillip RP, Borden BA, Galecki P, Ham SA, Patrick-Miller L, Hall JP, Hussain S, Danahey K, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polons..., Clin Pharmacol Ther, 1/1/2016

Books/Book Chapters

• Evidence Based Cardiology Consult 
  Chapter: Diagnosis, Prevention and Treatment of Hypertensive Heart Disease. 
  Page 51.0 - 58.0Sorrentino M, Bakris GLEditors: Stergiopoulos K, Brown DL.Springer-Verlag2014
• Hypertension 
  Chapter: Hypertension Managing CoMorbidities: Ischemic Heart Disease 
  Sorrentino, MJEditors: Oxford University Press.Bakris G, Baliga R2012
• Current Clinical Practice Series 
  Chapter: Cardiovascular Risk Assessment 
  Sorrentino MJEditors: Sorrentino MJ.Humana Press2011

Abstracts/Posters

• Level of education and type of insurance but not race predict control of hypertension in a diverse, high-risk population: The University of Chicago Study of hypertensi...
  Devore A, Blankstein R, Arnsdorf M, Bakris G, Sorrentino M, AHA QOC meeting, 1/1/2008
• Induction of hemodynamically significant left ventricular outflow tract obstruction in hypertensive hypertrophic cardiomyopathy during dobutamine stress echocardiography.
  Sorrentino MJ, Marcus R, Korcarz C, Weinert L, Bednarz J, Balasia B, Lang RM, J Amer Coll Cardiol, 1/1/1993
• Left ventricular mechanics of hyperkinetic cardiac function in hypertension
  Sorrentino M, Murphy M, Weinert L, Bednarz J, Gretler D, Marcus R, Circ, 1/1/1993

Lectures

• 2013 Master Medical Update for the Primary Care Physician 
  American Physician Institute for Advanced Professional Studies, Orlando, Florida - 10/11/2013
• 2013 Master Medical Update for the Primary Care Physician 
  American Physician Institute for Advanced Professional Studies, Orlando, Florida - 10/11/2013
• 16th Annual Primary Care Update - Session 1 
  Continuing Medical Education Institute, Inc, Marco Island, Florida - 3/18/2013

Other

• Redefining Hypertension — Assessing the New Blood-Pressure Guidelines 
  Matthew Sorrentino, MD, The New England Journal of Medicine
  https://www.doximity.com/articles/2591b462-6ead-4a72-8e1e-2a6949a78b9a
  UpToDate, Wolters Kluwer Health - 2012-11-02
• Review of, Hansen BC, Bray GA. The Metabolic Syndrome: Epidemiology, Clinical Treatment, and Underlying Mechanisms. Doody’s Review Service (on-line) 
  Sorrentino M
  http://www.doody.com
  1/1/2008
• Review of, Krentz AJ, Wong ND. Metabolic syndrome and cardiovascular disease, Doody’s Review Service (on-line). 
  Sorrentino MJ.
  http://www.doody.com
  1/1/2007